Sylvain Yon is delivering an oral presentation showcasing one of our lead assets: “First-in-class anti-TRPV6 antibody as a new therapeutic agent in cancer.”
The presentation takes place at the International Biotherapy Days 2026 held in Toulouse on 28th January 2026.
